Windsor Capital is pleased to announce the appointment of Gaet Tyranksi as Senior Advisor in its Tampa, Florida office
TAMPA, FLORIDA, USA, June 1, 2024 /EINPresswire.com/ — Tyranski, a C-level executive and visionary leader with over 15 years in the healthcare industry, has transitioned to M&A advisory. Tyranski’s extensive background, which includes board membership, executive leadership, strategic acquisitions, and driving both organic and inorganic growth in various industries, positions him as an invaluable asset to the Windsor Capital team.
As Senior Advisor with Windsor Capital, Tyranski is responsible for pairing companies and principals, who share the same commitment to growth, customer satisfaction and employee development, with capital markets to meet owner or business needs.
Prior to his current role, Tyranski served as President & CEO of BioDerm growing revenue 750% in 8 years while obtaining market leading margins. His visionary leadership and strategic acumen were underscored by the successful acquisition and integration of Wound Care Resources, Inc., a Durable Medical Equipment (DME) company specializing in wound care supplies and billing for VAD (heart disease mechanical implant) patients and the merger with Argentum Medical.
Prior to BioDerm, as President AST Americas at UK-based Synergy Health (now Steris), Tyranski oversaw sales and operations of the contract medical device sterilization and lab segments. Within two years, his region successfully established two state-of-the-art electron beam facilities in the United States, significantly bolstering both capacity and geographic reach. At Jabil, a fortune 150 manufacturing services company, Tyranski last held the role of Senior Business Unit Director (Healthcare).
There, he spearheaded the inception of Jabil’s single-use medical devices division, ultimately leading to the transformative acquisition of Nypro, Inc. During his tenure, Tyranski oversaw strategic medical device disposable expansion initiatives across key international markets, including Shenzhen, China, and Penang, Malaysia.
Windsor Capital, LLC is a full-service investment banking firm offering a wide range of advisory services including:
• Sell Side/Succession Transition Advisory – for business owners seeking a full or partial exit with strategic alignment, private equity, or family offices.
• Buy Side Advisory – for growing business seeking to acquire complementing or rival companies or expanding a regional/national footprint.
• Corporate/Capital Advisory – for companies seeking divestitures and capital restructuring including growth or working capital needs.
Windsor Capital’s team of professionals have a combined 200+ years of M&A and capital markets experience. Representative industries include healthcare, business services, aerospace & defense, artificial intelligence technology and agribusiness. Transaction structures include full business sale, succession planning, partial/partner business sale, sponsor backed divestitures, buy side advisory, corporate restructuring including distressed transactions as well as capital raises using both debt and equity.
For additional information, contact:
Lindsay Stapleton, Marketing Manager
LStapleton@windsorcapital-llc.com
Lindsay Stapleton
Windsor Capital
+1 8132962550
lstapleton@windsorcapital-llc.com
